BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11299776)

  • 1. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
    Lo YL; Liu FI; Yang JM; Cherng JY
    Anticancer Res; 2001; 21(1A):445-50. PubMed ID: 11299776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines.
    Lo Y; Liu F; Cherng J
    J Control Release; 2001 Sep; 76(1-2):1-10. PubMed ID: 11532308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.
    Lo YL
    Biochem Pharmacol; 2000 Nov; 60(9):1381-90. PubMed ID: 11008132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.
    Lo YL
    J Control Release; 2003 Jun; 90(1):37-48. PubMed ID: 12767705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
    Lo YL; Liu Y; Tsai JC
    Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
    Lo YL; Ho CT; Tsai FL
    Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line.
    Lo YL; Hsu CY; Huang JD
    Anticancer Res; 1998; 18(4C):3005-9. PubMed ID: 9713500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.
    Lo YL; Huang JD
    Biochem Pharmacol; 2000 Mar; 59(6):665-72. PubMed ID: 10677583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
    Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
    BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.
    Featherstone JM; Lwaleed BA; Speers AG; Hayes MC; Birch BR; Cooper AJ
    Urology; 2009 Aug; 74(2):378-84. PubMed ID: 19501884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
    Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
    Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells.
    Lo YL; Lee HP; Tu WC
    Int J Mol Sci; 2015 Sep; 16(9):22711-34. PubMed ID: 26393585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance by tacrolimus hydrate.
    Wu J; Furusawa S; Nakano S; Takahashi M; Chiba H; Takayanagi M; Takayanagi Y; Sasaki K
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):651-8. PubMed ID: 9121220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
    Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin.
    Kawazu K; Yamada K; Nakamura M; Ota A
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1738-44. PubMed ID: 10393043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells.
    Lo YL; Tu WC
    Chem Biol Interact; 2015 Dec; 242():13-23. PubMed ID: 26335193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.